How the ACA has aided gunshot victims

Since Medicaid was expanded under the Affordable Care Act (ACA), many patients wounded by gunshots have received treatment they needed, something they couldn’t access before—and a benefit that may be taken away if President-elect Donald Trump’s administration dismantles the ACA.

Stories of gunshot victims are chronicled in a recent New York Times article that outlines the economic burdens that keep some gunshot patients from getting treatment to properly heal. If unable to access occupational therapists, mental health professionals and corrective surgery down the line, patients sometimes develop life-long, permanent disabilities.

And Medicaid expansion wasn’t only good for patients. It was also good for trauma departments who saw revenue increase as more of their patients were insured and had a way to pay for services. If the ACA is repealed, there is no guarantee right now that the same patients seeking care in an emergency department would be insured in the same way, accorinding to the article.

To read more about how Medicaid expansion has provided coverage to gunshot victims, follow the link below:

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

California-based Acutus Medical has said its ongoing agreement to manufacture and distribute left-heart access devices for Medtronic is the company's only source of revenue. 

The scam took place over a period of seven years, resulting in Medicare being billed for more than $70 million in fraudulent claims for unnecessary scans. 

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.